ASCACORPORATION
Advance, Specialize, Communicate, AssureYour partner for solutions

ContentsContents

1Message2Services

3 -4Translation Services
Medical Writing Services
AI Translation Solutions
Science and Advertising Solutions
Marketing Support
Additional Services

Value

5 -6

Statements

7 -8Mission
VisionCore Value
Code of Conduct

1Policies

9Profile

9Slogan10

Message
Since its establishment in 1995, ASCA has provided translation and writing services not only to facilitate the dissemination ofJapanese medical technology, drug development, and medical research internationally, but also to help people understandtechnology and information.
Initially, the spread of Internet technology significantly boosted our business. However, the Internet environment wasstill in its infancy, and even a small translation assignment still entailed considerable time and effort for research prior
to delivery. All of the documents we handle contain vital information, so speed and efficiency are essential.
Today, technological innovations in IT are revolutionizing our work processes. Advances in AI translation technology
have also helped to significantly reduce the huge expenditure of time and effort spent on checking terminology andreference materials.
Nevertheless, humans continue to play a vital role in the preparatory and finishing processes.
By leveraging our medical and pharmaceutical translation and writing expertise and combining it with AI, we achieve
unequalled professionalism, quality, consistency, and speed.
This enables us to support scientific progress and global drug development.
Thanks to advances in technology, language barriers will soon disappear.
We are confident that by tearing down these walls, we can help to save lives and contribute to the realization of abetter future for all.
Generative AI technology will also revolutionize our work.
We believe that language has the power to safeguard our lives and by utilizing that power we will continue to forge
new paths and partnerships as we move forward into the future.
October 1, 2023

Eiko Ishioka
President
ASCA Corporation2

To benefit everyone's health and well-being by delivering translation andmedical writing services in medical, pharmaceutical and science sectors.

Services
Translation Services

Medical and Pharmaceutical Translation:
We specialize in translating documents across various life science fields, including pharmaceuticals, medical devices, legal affairs, and IT.
Our expertise and AI integration ensure both speed and accuracy. We work in English, Japanese, and other Asian and European languages.
Utilization of Translation Tools:
Our Computer Assisted Translation (CAT ) tools combined with our AI translation ensure fast and precise results.
Documents handled:
Basic research, Non-clinical studies
Clinical studies (Clinical trials）
Pharmaceutical development, Quality assurance
Manufacturing and Marketing approval applications
Safety information
Post-marketing documents
Legislation, Guideline, Notification
MarketingPR and Investor Relations
Research paper, Medical/ Scientific publication, Medical information
Utilization of Translation Tools:
Our Computer Assisted Translation (CAT ) tools combined with our AI translation ensure fast and precise results.
Languages:
Japanese, English, Chinese, other Asian and European languages

AI Translation Solutions
Glossary and Translation Collection:
We help you create language assets for future projects and AI learning.
AI Translation Engines:
We build unique AI translation engines tailored to your needs.
User Training and Post-editing:Our services include training and post-editing for optimal results.
MT consulting

3Medical Writing Services
Paper Writing :We create original research papers in English and Japanese based on the data provided by our clients.
Conference Materials :We support the creation of conference materials, including abstracts, slides, and posters.
Clinical Trial Documents :We create Japanese versions of clinical trial documents.
Post-market Materials: We develop post-market product information and promotional materials.
Post-market Materials :We offer customized publication-related seminars.
Planning/organization of seminars on publications

Science and Advertising Solutions

Marketing Support

Advertising:Leverage science to communicate your overseas
strategies, branding, and product promotions.

Content Planning:
We plan and create medical and scientific content, manage
editorial committees, and set up roundtable discussions.

• Sponsored Feature• Webinar• Job Posting• 3rd Party Email• Banner

Promotional Materials:
Our experts create scientifically sound promotional materials.
KOL and Literature Surveys:
We conduct research on academic information, including KOL
research and literature summaries.

Career Services:
We provide recruitment services forscientists worldwide.
Science Café:
Hear from researchers about their
published work and innovations.

Additional Services
Tape Transcription:
Japanese/English transcription services.
Interpretation:
Conference, consecutive, whispering, and AI interpretation services.

4Armed with advanced AI-assisted translation applications, we providetranslation and medical writing
services focused on the needs of the medical and pharmaceutical sectors at the cutting edge.

Value

Seven Reasons
Quality throughSelect Translators

Specialization in Medicaland Pharma (95% of Orders)

We assure quality through stringently selected translators (only 5% ofcandidates clear our high recruitment standards). Many of ASCA'sregistered translators and writers have science backgrounds such as
medicine and pharmacy. We also focus on training, holding study
sessions, providing feedback on customer reviews.

We specialize in the pharmaceutical and life science fields and provide awide range of services to meet various needs including translation,
submission support, medical writing, etc. Our clients are pharmaceuticalmanufacturers, related companies, universities and research institutions.
General science 2%
Respiratory 3%
Gastroenterology

Urology 1%
4%

Orthopedics
Hematology

4%4%

Cardiology

5%Ophthalmology

5%

Infection / vaccine

6%

oncology
29%

13%
Dermatology

6%

Inflammation / Immunology

8%10%

Data by domain (2021)

AIKO SciLingual ® Platform
We offer AIKO SciLingual, a specialized AI
medical/pharmaceutical translation platform forclients' in-house and training use.

5Endocrinology/ Metabolism

Neurology / Psychiatry

to Choose ASCAClient Trust(98.8% Repeat Orders)AI-assisted Translation(40% Faster Delivery)

The client-based repeat rate is 81.8%, and the project-based repeat
rate is 98.8%. Most of our requests come from acquaintances orintroductions from other departments. This leads to not only
one-time requests but also ongoing requests. We have gained ourclients' solid trust.

We have expedited delivery time by deploying our in-house
AI-assisted translation engine specializing in medical andpharmaceutical domains by incorporating independently
collected and translated data such as clinical and non-clinicalmedical documents, medical papers, etc. In addition to speeding
up translation work, we also create bilingual translations andglossaries, and custom engines.

Home page
19%

Others36%
Includes previous employment,
seminar participation, etc.

Introduction
45%

Background of the inquiry (2021)Partnership with
SciencISO27001
Information Management

We work in association with the periodical Science includingtranslation, advertising for branding, and recruitment etc.

We observe strict information management procedures
under ISO27001.

IS 598064 / ISO 27001
6

Statements
Armed with advanced AI-assisted translation applications,
we provide translation and medical writing services
focused on the needs of the medical and pharmaceuticalsectors at the cutting edge.

MissionTo benefit everyone's health and well-being by delivering translation andmedical writing services in medical, pharmaceutical and science sectors.

VisionYour Best Partner for All Life Science Solutions, Assisted by AICore Value
Strive for the future
Stay hungry for knowledge
Provide tailored solutions
Support with care
Respect all people

7

ASCA’s Policies

Policies
Security Policy
ASCA Corporation (“ASCA”) recognizes that it has a social responsibility to ensure information security in consideration of the characteristics
of its businesses that handle various types of information, including our customers’ information relating to documentation services in thelife sciences field, and pursues this responsibility as an important, ongoing issue. Accordingly, ASCA has established the “Information
Security Policy” detailed below and implements information security measures in compliance with that policy.
1. Purpose
ASCA shall engage appropriately in information security management andprotection of information assets. ASCA shall prevent information security
breaches such as leaks, falsification and theft. The purpose of ASCA’s
information security management is to build a partnership of trust with ourclients, partners and the public at large.
2. Scope
ASCA shall apply its Information Security Policy to all the information assets
it owns and to all its employees.
3. Information Management System
ASCA shall be proactive in information security management by setting up
a security committee to implement information security measures, making
an accurate assessment of ASCA's information security status and ensuringthat any necessary action can be taken speedily.
4. Actions
ASCA shall ensure and maintain the confidentiality, integrity and availabilityof the information assets it owns.
ASCA shall strictly comply with the requirements of legislation andregulations concerning information security.

ASCA shall strictly comply with security requirements as agreed in thecontracts we sign.
ASCA shall protect information assets chiefly comprising customer
information and shall regularly update the protection so that if any major
damage or accident should occur, it will be in a position to swiftly resume
business activities.
ASCA shall provide regular education and training on information security
to all employees, including executive officers.
ASCA shall firmly establish and maintain its information security
management system by adopting criteria that evaluate information
security risks and engaging in appropriate risk management.
5. Ongoing Improvements
ASCA shall review its Information Security Policy and information security
management system on a continuous basis and make improvements, inline with the changes that impact on the risks surrounding the information
assets that ASCA handles.

First Adopted: June 21, 2013 Revised: July 1, 2023 Eiko Ishioka President
ASCA Corporation

Quality Policy
ASCA Corporation (“ASCA”) provides documentation services in the life sciences field to the quality standards that our customers demand interms of deliverables, delivery dates, costs, etc. ASCA is sensitive to market demands, contributes to people and society through its
business activities, and thereby seeks to create new values. Accordingly, ASCA has established a “Quality Policy” and continues to provide
high-quality products and services that satisfy our customers.
1. Identifying Customer Needs and Expectations
ASCA shall thoroughly ascertain customer needs, utilize the latest
technologies and expertise, and provide excellent deliverables. ASCA shallalso meet delivery dates and optimize cost management, placing thehighest priority on satisfying customer expectations.

5. Enhancing Human Resources
ASCA has trained highly skilled personnel and established a solid quality
control system. Training shall be provided to employees and partners
regularly to ensure they have high levels of expertise and operational skills
so that reliable services can be provided.

2. Establishing Quality Targets
ASCA's quality targets shall indicate the direction of activities for providing
high-quality documentation services. Specific numerical values and indicesshall be set for the quality of deliverables, strict compliance with delivery
dates, cost management, etc., and action plans shall be developed forachieving the targets, including allocation of resources.

6. Compliance
ASCA shall observe agreements with customers regarding the quality ofservices to be provided, shall be fully conversant with relevant laws andregulations, and shall comply with same.

3. Establishing an Efficient Operation ProcessStandardization of the operation process is important to providing quality
at a consistent level. ASCA shall establish standard operating procedures todefine operation procedures and rules and to reduce variations in quality.

7. Review of this Policy
In consideration of various community issues, changes in people's values
and lifestyles, technological innovation, and expansion of business fields,
ASCA shall review this Policy as necessary and amend it where appropriate.

4. Continuous Improvement
Through continuous improvement activities, ASCA shall engage in activities
to achieve quality targets. In addition to regular reviews of operation
process, problems shall be reported promptly and shared so that quality
control processes and operation methods can be continuously improved.

ASCA shall highly value the trust its customers place in ASCA and shall respond in good faith to the quality demands of both customers and society.
Through our efforts to attain those goals, ASCA shall build on the trust that is placed in us.
First Adopted: July 1, 2023 Eiko Ishioka President
ASCA Corporation8ProfileCompany name

ASCA Corporation

EstablishedApril. 1995

RepresentativeDirector

Eiko Ishioka

Directors

Eriko Imai,
Ayumi Imanaka

Board members

Hiroshi Tamura, Academic Adviser Professor, Kyoto University, MD, Ph.D (Medicine), ScM (Epidemiology)
Osaka Head Office

Hirano-cho Yachiyo Building, 1-8-13 Hirano-cho, Chuo-ku, 541-0046 Osaka
TEL: 06-6202-6272 FAX: 06-6202-6271

Address / ContactTokyo BranchShibaura TY Building, 1-14-5 Shibaura, Minato-ku, 105-0023 Tokyo
TEL: 03-6459-4174 FAX: 03-6459-4175

Paid in CapitalServices

Main clients

Related party

Affiliations

Certification andacquisition

30,000,000 JPY
Pharmaceutical and scientific translation/English editing/transcription of medical literature/planning and editing/interpretation
Pharmaceutical and biotechnology manufacturers, medical device manufacturers, Medical publishers,
Pharmaceutical agencies, universities, research institutes, CROs (Contract Development Organizations)
American Association for the Advancement of Science (AAAS)Japan Translation Federation (JTF)
Asia Pacific Machine Translation Association (AAMT)
Eruboshi Certification
ISO 17100 Certification
ISO 27001 Certification

IS 598064 / ISO 27001

9ISO 17100
JSAT017

Language isvital to life.
If that drug had been approved, we might have cured that disease.
If that therapy had been more available, we might have saved that life.
Language support for healthcare is a vital instrument in safeguarding human life.

We must communicate the latest information on Japanese healthcare out tothe rest of the world and relay information from the world into Japan.
ASCA provides the bridge between Japan and the world.
Our medical and pharmaceutical translation and writing services serve as the bridgethat communicates our clients to their customers, in Japan and the world.
Language expertise will support and safeguard human life.
This is ASCA's core conviction.
Now and always, we strive to provide the best expertise in language.

10ASCA Corporation
Providing translation, medical writing, and AI solutions in the life science field
Osaka Head Office:Hirano-cho Yachiyo Building, 1-8-13 Hirano-cho, Chuo-ku, 541-0046 Osaka
TEL:06-6202-6272 FAX:06-6202-6271
Tokyo Branch:
Shibaura TY Building, 1-14-5 Shibaura, Minato-ku, 105-0023 TokyoTEL:03-6459-4174 FAX:03-6459-4175
https://www.asca-co.com

Home pageNote

ASCA Bulletin